User profiles for Timothy J. Harris
Timothy J. HarrisLudwig-Maximilians-Universität München (LMU) Verified email at physik.uni-muenchen.de Cited by 7 |
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
…, J Ruzevick, N Durham, C Meyer, TJ Harris… - International Journal of …, 2013 - Elsevier
PURPOSE: Glioblastoma multiforme (GBM) is the most common primary brain tumor in
adults, and radiation is one of the main treatment modalities. However, cure rates remain low …
adults, and radiation is one of the main treatment modalities. However, cure rates remain low …
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity
TJ Harris, JF Grosso, HR Yen, H Xin… - The Journal of …, 2007 - journals.aai.org
STAT3 activation has been observed in several autoimmune diseases, suggesting that
STAT3-mediated pathways promote pathologic immune responses. We provide in vivo evidence …
STAT3-mediated pathways promote pathologic immune responses. We provide in vivo evidence …
[HTML][HTML] LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems
JF Grosso, CC Kelleher, TJ Harris… - The Journal of …, 2007 - Am Soc Clin Investig
Lymphocyte activation gene-3 (LAG-3) is a cell-surface molecule with diverse biologic
effects on T cell function. We recently showed that LAG-3 signaling is important in CD4 + …
effects on T cell function. We recently showed that LAG-3 signaling is important in CD4 + …
A role for the transcription factor Helios in human CD4+ CD25+ regulatory T cells
D Getnet, JF Grosso, MV Goldberg, TJ Harris… - Molecular …, 2010 - Elsevier
Relative upregulation of the Ikaros family transcription factor Helios in natural regulatory T
cells (Tregs) has been reported by several groups. However, a role for Helios in regulatory T …
cells (Tregs) has been reported by several groups. However, a role for Helios in regulatory T …
Tc17 CD8 T cells: functional plasticity and subset diversity
HR Yen, TJ Harris, S Wada, JF Grosso… - The Journal of …, 2009 - journals.aai.org
IL-17-secreting CD8 T cells (Tc17) have been described in several settings, but little is known
regarding their functional characteristics. While Tc1 cells produced IFN-γ and efficiently …
regarding their functional characteristics. While Tc1 cells produced IFN-γ and efficiently …
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
…, L Zhen, RM Tuder, JF Grosso, TJ Harris… - Blood, The Journal …, 2007 - ashpublications.org
Expression of the PD-1 receptor on T cells has been shown to provide an important inhibitory
signal that down-modulates peripheral effector responses in normal tissues and tumors. …
signal that down-modulates peripheral effector responses in normal tissues and tumors. …
[HTML][HTML] Primer on tumor immunology and cancer immunotherapy
TJ Harris, CG Drake - Journal for immunotherapy of cancer, 2013 - Springer
Individualized cancer therapy is a central goal of cancer biologists. Immunotherapy is a
rational means to this end—because the immune system can recognize a virtually limitless …
rational means to this end—because the immune system can recognize a virtually limitless …
Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner
TJ Harris, EL Hipkiss, S Borzillary, S Wada… - The …, 2008 - Wiley Online Library
BACKGROUND Cancer immunotherapy refers to an array of strategies intended to treat
progressive tumors by augmenting a patient's anti‐tumor immune response. As immunotherapy …
progressive tumors by augmenting a patient's anti‐tumor immune response. As immunotherapy …
The effect of pulsatile flow on intrathecal drug delivery in the spinal canal
HDM Hettiarachchi, Y Hsu, TJ Harris… - Annals of biomedical …, 2011 - Springer
Clinical studies have shown that drugs delivered intrathecally distribute much faster than
can be accounted for by pure molecular diffusion. However, drug transport inside the …
can be accounted for by pure molecular diffusion. However, drug transport inside the …
[HTML][HTML] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
…, K Yoshimura, HR Yen, D Getnet, TJ Harris… - Journal of translational …, 2013 - Springer
Background The FDA recently approved an anti-CTLA-4 antibody (Iplimumab) for the
treatment of metastatic melanoma. This decision was based on Phase III results, which …
treatment of metastatic melanoma. This decision was based on Phase III results, which …